Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237597 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04237597 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT04237597, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.
Interventions
- DRUG CSG452
- DRUG K-877
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2020-03-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04237597
The ClinicalTrials.gov registry entry for NCT04237597 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CSG452 is the first listed.
NCT04237597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04237597 about?
NCT04237597 is a clinical study titled "Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers". A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.
What is the current status of trial NCT04237597?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2019-12-17. Estimated completion is 2020-03-04.
What interventions are being tested in trial NCT04237597?
The interventions under investigation include: CSG452 (DRUG), K-877 (DRUG).
Who is sponsoring clinical trial NCT04237597?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.